Evidence map›Paper›PMID 36505484›Full record

ArticleFrontiers in immunology2022

Dysregulation of iron metabolism modulators in virologically suppressed HIV-infected patients.

Vanesa Garrido-Rodríguez, Ana Isabel Álvarez-Ríos, Israel Olivas-Martínez, María Del Mar Pozo-Balado, Ángel Bulnes-Ramos, Manuel Leal, Yolanda María Pacheco

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Vanesa Garrido-RodríguezImmunology Service, Institute of Biomedicine of Seville, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University, Seville, Spain.
Ana Isabel Álvarez-RíosBiochemistry Department, Virgen del Rocío University Hospital, Seville, Spain.
Israel Olivas-MartínezImmunology Service, Institute of Biomedicine of Seville, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University, Seville, Spain.
María Del Mar Pozo-BaladoImmunology Service, Institute of Biomedicine of Seville, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University, Seville, Spain.
Ángel Bulnes-RamosImmunology Service, Institute of Biomedicine of Seville, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University, Seville, Spain.
Manuel LealInternal Medicine Service, Hospital Viamed, Santa Ángela de la Cruz, Seville, Spain.
Yolanda María PachecoImmunology Service, Institute of Biomedicine of Seville, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital/CSIC/University, Seville, Spain.
Instituto de Biomedicina de Sevilla · ESHospital Universitario Virgen del Rocío · ESHospital Viamed Valvanera · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Iron metabolism plays an essential role in cellular functions. Since virologically suppressed chronic HIV-infected subjects under effective antiretroviral treatment (ART) exhibit a persistent immune dysfunction that leads to comorbidities, iron homeostasis may be relevant in this context. We aimed to explore iron metabolism in virologically suppressed chronic HIV infected subjects under a successful ART. Methods: In this retrospective study, traditional iron metabolism biomarkers (total iron, ferritin, transferrin, and transferrin saturation index), as well as soluble transferrin receptor (sTfR), hepcidin, and inflammatory markers were determined in virologically suppressed chronic HIV-infected subjects under at least 2 years of ART (HIV) who also had >350 CD4-T-cells/mm Results: We selected samples from HIV-infected subjects (aged 42[34-47], 95% males), young age-matched (aged 40[30-58], 60% males), and elderly controls (aged 82[78-88], 100% males). Compared to both healthy (Young and Elderly) groups, HIV exhibited decreased iron, transferrin saturation, and sTfR, and increased ferritin, but similar hepcidin levels. Notably, associations between sTfR and iron (Young, Conclusions: Virologically suppressed chronic HIV-infected patients under successful ART exhibit altered levels of iron metabolism modulators suggesting a complex functional iron deficiency.

Indexed as

Anemia, Iron-DeficiencyIron DeficienciesAdultAgedAnti-Retroviral AgentsFemaleFerritinsHumansIronMaleMiddle AgedReceptors, TransferrinRetrospective StudiesAnti-Retroviral AgentsFerritinsIronReceptors, Transferrinchronic HIV infectionhepcidininflammationiron metabolismsoluble transferrin receptor

Identifiers

PMID36505484
PMCPMC9732230
OpenAlexW4309933671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.